Global Autoimmune Disease Diagnostics Market

Global Autoimmune Disease Diagnostics Market Size, Trends, and Analysis - Forecasts to 2026 By Type (Systemic Autoimmune Disease Diagnostics [Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE), and Others] and Localized Autoimmune Disease Diagnostics [Multiple Sclerosis, Type 1 Diabetes, Hashimotos Thyroiditis, Idiopathic Thrombocytopenic Purpura, and Others]), By Region (North America, Europe, Asia Pacific, MEA, And CSA); Competitive Landscape, Company Market Share Analysis, and Competitor Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on December 19 2024 with the latest and most recent market numbers

Global Autoimmune Disease Diagnostics Market: Insights

Autoimmune disease is a medical condition where the immune system of the human body fallaciously attacks certain healthy body parts. In usual cases, the immune system protects the body from bad bacteria and harmful external microorganisms by using the fighter cells in the body. However, in conditions like autoimmune disease, the immune system with its fighter cells attack the healthy part or organs of the body with its proteins like autoantibodies, which basically attack the healthy cells in these parts. While some autoimmune diseases like systemic lupus erythematous (SLE) attack the entire body, others, like type 1 diabetes, attack a single organ like the pancreas. These increasing cases and the percentage of the population with autoimmune disease accelerate growth within the autoimmune disease diagnostics market.

Studies and surveys have shown that a country like the United States reports approximately more than 23.5 million people with autoimmune diseases every year. These surveys have also proved the fact that autoimmune diseases are more typical in females than in males. These autoimmune diseases are also one of the primary causes of death in countries like these. This increasing number of autoimmune disease has severe implications if left undiagnosed or untreated. Thus, countries like the United States tremendously contribute to the increasing growth of autoimmune disease diagnostics in the global market. Studies have shown that there are approximately 80 types of autoimmune diseases, out of which few attack one organ at a time. Studies have also been unsuccessful in figuring the root cause behind autoimmune diseases, although some have vaguely stated that these diseases can be related to genetics and family history. Besides genetics of family inheritance, some changing environmental factors can have an impact on body working or exposure to various bacteria that trigger autoimmune diseases. Also, there are high chances or risks of a person developing another autoimmune disease after getting affected or diagnosed by one in the past. This increasing awareness about the risks and consequences of autoimmune diseases is making people opt for autoimmune disease diagnostics as a part of regular check-ups to be assured and take necessary precautions, thus boosting the demand and growth in the autoimmune disease diagnostics market.

The symptoms attributed by a person with autoimmune disease are pretty similar and can overlap with the systems of other diseases, making it difficult to diagnose. However, the technological advancements in the diagnostic processes, along with automated equipment and techniques, have made it easy for professionals to diagnose these autoimmune diseases accurately. Medical science has proved that there is no specific management for autoimmune diseases. However, early diagnosis can enable doctors to recommend treatments that can slow down the progression and impact of autoimmune disease and can be beneficial for a better quality of life. Also, despite having no concrete cure, doctors do prescribe drugs and medications for treating autoimmune diseases, and easy accessibility and availability of these antibiotics and medications have also been propelling growth in the autoimmune disease diagnostics market.

Today, many governmental bodies have also been encouraging the respective medical and healthcare sectors to undertake sufficient research and development in order to handle the increasing autoimmune diseases more efficiently. This increased ratio of research and development is also enabling professionals to adopt techniques that deliver a quick and accurate diagnosis, which can be relied on and subsequently be treated. In recent years, the medical sector has also witnessed increased investments through various authorities, thus boosting growth in the autoimmune disease diagnostics market.

global autoimmune disease diagnostics market

Global Autoimmune Disease Diagnostics Market: By Type

Based on the type, the autoimmune disease diagnostics market is categorized as systemic autoimmune disease diagnostics and localized autoimmune disease diagnostics. Amongst these, localized autoimmune disease diagnostics holds the largest share, thus dominating the market over systemic autoimmune disease diagnostics. The rate of autoimmune diseases affecting a single organ or body part at a time is comparatively more than the autoimmune diseases affecting multiple organs or body parts at a time. Thus, localized autoimmune disease diagnostics are utilized significantly within the medical sector by professionals compared to systemic autoimmune disease diagnostics. The increasing rate of emerging organ-specific specialists also subsequently increases the demand for localized autoimmune disease diagnostics. Type 1 diabetes affecting a single pancreatic organ is prevalent among various countries in the majority, thus requiring localized autoimmune disease diagnostics. Also, Hashimoto's Thyroiditis is commonly reported in more significant numbers in various countries.

However, followed by localized autoimmune disease diagnostics, systemic autoimmune disease diagnostics is also expected to witness fast growth within the market throughout the forecast period. Systemic autoimmune diseases usually are seen within multiple organs or body parts at the same time. These are majorly classified or segmented into vasculitis disorders and rheumatological disease. The increasing number of cases and severity of autoimmune diseases in various countries are demanding diagnostics like systemic autoimmune disease diagnostics, which are more advanced and can be used on various organs simultaneously to get more efficient and effective diagnostic results.

asia pacific autoimmune disease diagnostics market

Global Autoimmune Disease Diagnostics Market: By Region

Based on regional segmentation, North America holds the largest share in the market. Organizations like the National Institute of Health (NIH) have been working in the North American region to develop research on various medical fields and areas. Organizations like these have contributed tremendously in identifying 80 types of autoimmune diseases. Also, countries like the United States report having autoimmune disease as one of the top ten reasons behind increasing death rates in the country.

However, Asia Pacific is expected to witness the fastest growth within the market throughout the forecast period. Countries like China and India have an enormous population, thus having significant autoimmune diseases being reported every year. With their improving medical sector, these countries are gaining more and more awareness about these diseases. They are encouraging their respective healthcare sectors to undertake research and development to manage the increased ratios of these, thus accelerating growth in the diagnostics market. India has also witnessed an increase in the number of professionals or organ-specific specialists and massive investments into the medical sector, thus increasing the demand for more accurate diagnostics. Improving technology and advancements in technical processes also enable the professionals to effectively deal with the severity of the disease, thus accelerating growth within the autoimmune disease diagnostics market of the APAC region.

Global Autoimmune Disease Diagnostics Market Share & Competitor Analysis

Abbott Laboratories, AESKU.Diagnostics GmbH & Co. KG, Crescendo Bioscience, Inc., Bio-Rad Laboratories, Inc., bioMerieux SA, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Beckman Coulter, Inc., SQI Diagnostics, Quest Diagnostics, EUROIMMUN AG, INOVA Diagnostics, Inc., and Hemagen Diagnostics, Inc., are few prominent competitors in the market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1   Methodology

1.1    Market Scope & Definitions

1.2    Estimates & Forecast Calculation

1.3    Historical Data Overview And Validation

1.4    Data Sources

1.4.1    Secondary

1.4.2    Primary

Chapter 2   Report Outlook

2.1    Global Autoimmune Disease Diagnostics Industry Overview, 2019-2026

2.1.1    Industry Overview

2.1.2    Type Overview

2.1.3    Regional Overview

Chapter 3   Global Autoimmune Disease Diagnostics Market Trends

3.1    Market Segmentation

3.2    Industry Background, 2019-2026

3.3    Market Key Trends

3.3.1    Positive Trends

3.3.1.1    Technology Advancement in Healthcare Industry

3.3.1.2    Increasing Expenditure on Healthcare AI

3.3.2    Industry Challenges

3.3.2.1    Limited Study and Industry Participants

3.4    Prospective Growth Scenario

3.4.1    Type Growth Scenario

3.5    COVID-19 Influence over Industry Growth

3.6    Porter’s Analysis

3.7    PESTEL Analysis

3.8    Value Chain & Supply Chain Analysis

3.9    Regulatory Framework

3.9.1    North America

3.9.2    Europe

3.9.3    APAC

3.9.4    LATAM

3.9.5    MEA

3.10    Technology Overview

3.11    Market Share Analysis, 2020

3.11.1    Company Positioning Overview, 2020

Chapter 4   Global Autoimmune Disease Diagnostics Market, By Type

4.1    Type Outlook

4.2    Systemic Autoimmune Disease Diagnostics

4.2.1    Market Size, By Region, 2019-2026 (USD Million)

4.2.2    Rheumatoid Arthritis

            4.2.2.1    Market Size, By Region, 2019-2026 (USD Million)

4.2.3    Ankylosing Spondylitis

            4.2.3.1    Market Size, By Region, 2019-2026 (USD Million)

4.2.4    Systemic Lupus Erythematosus (SLE)

            4.2.4.1    Market Size, By Region, 2019-2026 (USD Million)

4.2.5    Others

            4.2.5.1    Market Size, By Region, 2019-2026 (USD Million)

4.3    Localized Autoimmune Disease Diagnostics

4.3.1    Market Size, By Region, 2019-2026 (USD Million)

4.3.2    Multiple Sclerosis

           4.3.2.1    Market Size, By Region, 2019-2026 (USD Million)

4.3.3    Type 1 Diabetes

           4.3.3.1    Market Size, By Region, 2019-2026 (USD Million)

4.3.4    Hashimoto's Thyroiditis

           4.3.4.1    Market Size, By Region, 2019-2026 (USD Million)

4.3.5    Idiopathic Thrombocytopenic Purpura

           4.3.5.1    Market Size, By Region, 2019-2026 (USD Million)

4.3.6    Others

           4.3.6.1    Market Size, By Region, 2019-2026 (USD Million)

Chapter 5   Global Autoimmune Disease Diagnostics Market, By Region

5.1    Regional outlook

5.2    North America

5.2.1    Market Size, By Country 2019-2026 (USD Million)

5.2.2    Market Size, By Type, 2019-2026 (USD Million)

5.2.4    U.S.

5.2.4.1    Market Size, By Type, 2019-2026 (USD Million)

5.2.5    Canada

5.2.5.1    Market Size, By Type, 2019-2026 (USD Million)

5.3    Europe

5.3.1    Market Size, By Country 2019-2026 (USD Million)

5.3.2    Market Size, By Type, 2019-2026 (USD Million)

5.3.4    Germany

5.2.4.1    Market Size, By Type, 2019-2026 (USD Million)

5.3.5    UK

5.3.5.1    Market Size, By Type, 2019-2026 (USD Million)

5.3.6    France

5.3.6.1    Market Size, By Type, 2019-2026 (USD Million)

5.3.7    Italy

5.3.7.1    Market Size, By Type, 2019-2026 (USD Million)

5.3.8    Spain

5.3.8.1    Market Size, By Type, 2019-2026 (USD Million)

5.3.9    Russia

5.3.9.1    Market Size, By Type, 2019-2026 (USD Million)

5.4    Asia Pacific

5.4.1    Market Size, By Country 2019-2026 (USD Million)

5.4.2    Market Size, By Type, 2019-2026 (USD Million)

5.4.4    China

5.4.4.1    Market Size, By Type, 2019-2026 (USD Million)

5.4.5    India

5.4.5.1    Market Size, By Type, 2019-2026 (USD Million)

5.4.6    Japan

5.4.6.1    Market Size, By Type, 2019-2026 (USD Million)

5.4.7    Australia

5.4.7.1    Market Size, By Type, 2019-2026 (USD Million)

5.4.8    South Korea

5.4.8.1    Market Size, By Type, 2019-2026 (USD Million)

5.5    Latin America

5.5.1    Market Size, By Country 2019-2026 (USD Million)

5.5.2    Market Size, By Type, 2019-2026 (USD Million)

5.5.4    Brazil

5.5.4.1    Market Size, By Type, 2019-2026 (USD Million)

5.5.5    Mexico

5.5.5.1    Market Size, By Type, 2019-2026 (USD Million)

5.5.6    Argentina

5.5.6.1    Market Size, By Type, 2019-2026 (USD Million)

5.6    MEA

5.6.1    Market Size, By Country 2019-2026 (USD Million)

5.6.2    Market Size, By Type, 2019-2026 (USD Million)

5.6.4    Saudi Arabia

5.6.4.1    Market Size, By Type, 2019-2026 (USD Million)

5.6.5    UAE

5.6.5.1    Market Size, By Type, 2019-2026 (USD Million)

5.6.6    South Africa

5.6.6.1    Market Size, By Type, 2019-2026 (USD Million)

Chapter 6   Company Landscape

6.1    Competitive Analysis, 2020

6.2    Abbott Laboratories

6.2.1    Company Overview

6.2.2    Financial Analysis

6.2.3    Strategic Positioning

6.2.4    Info Graphic Analysis

6.3    AESKU.Diagnostics GmbH & Co. KG

6.3.1    Company Overview

6.3.2    Financial Analysis

6.3.3    Strategic Positioning

6.3.4    Info Graphic Analysis

6.4    Crescendo Bioscience, Inc.

6.4.1    Company Overview

6.4.2    Financial Analysis

6.4.3    Strategic Positioning

6.4.4    Info Graphic Analysis

6.5    Bio-Rad Laboratories, Inc.

6.5.1    Company Overview

6.5.2    Financial Analysis

6.5.3    Strategic Positioning

6.5.4    Info Graphic Analysis

6.6    bioMerieux SA

6.6.1    Company Overview

6.6.2    Financial Analysis

6.6.3    Strategic Positioning

6.6.4    Info Graphic Analysis

6.7    F. Hoffmann-La Roche Ltd

6.7.1    Company Overview

6.7.2    Financial Analysis

6.7.3    Strategic Positioning

6.7.4    Info Graphic Analysis

6.8    Siemens Healthineers

6.8.1    Company Overview

6.8.2    Financial Analysis

6.8.3    Strategic Positioning

6.8.4    Info Graphic Analysis

6.9    Beckman Coulter, Inc.

6.9.1    Company Overview

6.9.2    Financial Analysis

6.9.3    Strategic Positioning

6.9.4    Info Graphic Analysis

6.10    SQI Diagnostics

6.10.1    Company Overview

6.10.2    Financial Analysis

6.10.3    Strategic Positioning

6.10.4    Info Graphic Analysis

6.11    Quest Diagnostics

6.11.1    Company Overview

6.11.2    Financial Analysis

6.11.3    Strategic Positioning

6.11.4    Info Graphic Analysis

6.12    EUROIMMUN AG

6.12.1    Company Overview

6.12.2    Financial Analysis

6.12.3    Strategic Positioning

6.12.4    Info Graphic Analysis

6.13    INOVA Diagnostics, Inc.

6.13.1    Company Overview

6.13.2    Financial Analysis

6.13.3    Strategic Positioning

6.13.4    Info Graphic Analysis

6.14    Hemagen Diagnostics, Inc.

6.14.1    Company Overview

6.14.2    Financial Analysis

6.14.3    Strategic Positioning

6.14.4    Info Graphic Analysis

6.15    Other Companies

6.15.1    Company Overview

6.15.2    Financial Analysis

6.15.3    Strategic Positioning

6.15.4    Info Graphic Analysis

The Global Autoimmune Disease Diagnostics Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Autoimmune Disease Diagnostics Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The global autoimmune disease diagnostics market size is projected to grow CAGR value of 8.9% between 2021 to 2026.
Key and innovative vendors in the autoimmune disease diagnostics market include Abbott Laboratories, AESKU. Diagnostics GmbH & Co. KG, Crescendo Bioscience, Inc., Bio-Rad Laboratories, Inc., bioMerieux SA, F. Hoffmann-La Roche Ltd, Siemens Healthiness, Beckman Coulter, Inc., SQI Diagnostics, Quest Diagnostics, EUROIMMUN AG, INOVA Diagnostics, Inc., and Hemagen Diagnostics, Inc., among others.
The North American region is estimated to hold the largest share of the autoimmune disease diagnostics market.
Supply chain issues and lockdowns have restricted the number of diagnostic procedures for autoimmune diseases being performed during the pandemic. This in turn has delayed the adoption of autoimmune disease diagnostics and hampered the growth of the market. The market is expected to bounce back as hospitals and other healthcare facilities return to regular working conditions.
The growing incidence of autoimmune diseases, growing awareness of autoimmune diseases, growing number of autoimmune tests, and the growing investment in diagnostic and healthcare facilities by governments are the major drivers of the autoimmune disease diagnostics market.

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius